Area of research
Molecular Biology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Ferroptosis and cancer prognosis, Epigenetics and DNA Methylation, RNA modifications and cancer, and Cancer, Lipids, and Metabolism.
KMT2D loss drives adeno-to-squamous transition and sensitizes TKI-resistant lung cancer to AURKA inhibition.
Ferroptosis in cancer: revealing the multifaceted functions of mitochondria
Ferroptosis in cancer: revealing the multifaceted functions of mitochondria.
High-adhesion ovarian cancer cell resistance to ferroptosis: The activation of NRF2/FSP1 pathway by junctional adhesion molecule JAM3.
Chromatin looping-based CRISPR screen identifies TLK2 as chromatin loop formation regulator in cancer stemness plasticity.
Machine learning constructs a ferroptosis related signature for predicting prognosis and drug sensitivity in lung cancer.
Tumor-associated macrophage subtypes on cancer immunity along with prognostic analysis and SPP1-mediated interactions between tumor cells and macrophages
Tumor-associated macrophage subtypes on cancer immunity along with prognostic analysis and SPP1-mediated interactions between tumor cells and macrophages.
Targeting PAX8 sensitizes ovarian cancer cells to ferroptosis by inhibiting glutathione synthesis.
Photobiomodulation therapy moderates cancer cachexia-associated muscle wasting through activating PI3K/AKT/FoxO3a pathway.
The suppression of cervical cancer ferroptosis by macrophages: The attenuation of ALOX15 in cancer cells by macrophages-derived exosomes
Chronic stress in solid tumor development: from mechanisms to interventions
The suppression of cervical cancer ferroptosis by macrophages: The attenuation of ALOX15 in cancer cells by macrophages-derived exosomes.
Targeting lipid metabolism for ferroptotic cancer therapy.
Chronic stress in solid tumor development: from mechanisms to interventions.
Targeting ZDHHC9 potentiates anti-programmed death-ligand 1 immunotherapy of pancreatic cancer by modifying the tumor microenvironment.
Editorial: Targeting cancer cell intracellular metabolism as a strategy against therapy resistance.
Targeting lipid metabolism for ferroptotic cancer therapy
Identification of ferroptosis-related signature with potential implications in prognosis and immunotherapy of renal cell carcinoma
Identification of ferroptosis-related signature with potential implications in prognosis and immunotherapy of renal cell carcinoma.
Cisplatin-induced ototoxicity: Updates on molecular mechanisms and otoprotective strategies
Targeting tumor-associated macrophages: A potential treatment for solid tumors.
Cancer cachexia: molecular mechanism and pharmacological management.
Targeting autophagy to overcome drug resistance: further developments.
Downregulation of MCL-1 and upregulation of PUMA using mTOR inhibitors enhance antitumor efficacy of BH3 mimetics in triple-negative breast cancer
CQ synergistically sensitizes human colorectal cancer cells to SN-38/CPT-11 through lysosomal and mitochondrial apoptotic pathway via p53-ROS cross-talk
Inhibition of Bcl-xL overcomes polyploidy resistance and leads to apoptotic cell death in acute myeloid leukemia cells
Aurora kinase A inhibition-induced autophagy triggers drug resistance in breast cancer cells